Michael I.

Michael I. has extensive experience in regulatory affairs, specializing in biotechnology and compliance for genetically modified crops. They held positions at companies such as DuPont Pioneer and Monsanto, focusing on risk assessment and import applications in the European Union and beyond. Currently, Michael serves as a Regulatory Affairs CMC Biologics Expert at Galderma while also contributing to industry initiatives at EuropaBio from 2009 to 2014. Earlier, they managed lifecycle activities for recombinant drug products at Shire and have consulted in regulatory affairs for various life sciences products. Michael's academic background includes a role as a master student and trainee at Nestlé, where they studied proteomics and physiology.